Today for AI
HOT RADAR
industryHEAT 11.5°

AI CURATED HOT STORY · 10/31/2026

Neuralink Blindsight Device Ready for Regulatory Approval to Restore Vision

1 reports archived1 independent sourcesupdated 10/31/2026, 23:13:20
Synthesis & Latest Updates
1 Sources Cross-Validated

Elon Musk announced that Neuralink's second brain-computer interface product, Blindsight, has completed engineering development and awaits regulatory approval for human trials. The device aims to restore vision in the blind by directly stimulating the visual cortex, though no confirmed human trial results have been published yet.

LATEST/Elon Musk announced that Neuralink's second brain-computer interface product, Blindsight, has completed engineering development and awaits regulatory approval for human trials. The device aims to restore vision in the blind by directly stimulating the visual cortex, though no confirmed human trial results have been published yet.

Hourly heat curve

2 fully observed hours
Fewer than 3 fully observed hours; trend not plotted yet.

Coverage timeline

Total 1 reports · Latest first
  1. IT之家 · 智能时代T2·68 pts

    Neuralink Blindsight Device Ready for Regulatory Approval to Restore Vision

    • Neuralink's Blindsight device has finished engineering development and is awaiting regulatory approval (e.g., FDA) to begin human implantation trials.
    • The technology operates inversely: converting camera images into electrical signals directly inputted into the brain's visual cortex, bypassing damaged eyes and optic nerves.
    • Current data relies on long-term animal studies (monkeys implanted for three years); there are no publicly confirmed human clinical trial results or quantified performance metrics yet.